Insulet Corporation PODD NASDAQ

Insulet Corporation (PODD) reported total assets of $3.19B and total liabilities of $1.68B for fiscal year 2025, resulting in total equity of $1.52B.

The company held $716.1M in cash and short-term investments. Total debt stood at $1.05B, with net debt of $334.7M. The Debt-to-Equity (D/E) ratio was 0.69 (moderate).

Current ratio is 2.78, indicating strong short-term liquidity. Interest coverage is 5.9x (adequate).

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (80/100) — Total assets $3.19B and equity $1.52B support the company's competitive scale
• VALUE (42/100) — Debt-to-Equity 0.69 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 74/100 with 4/7 criteria passed.

ABT

Abbott Laboratories

$101.07

+0.38%

SYK

Stryker Corporation

$345.88

-0.39%

EW

Edwards Lifesciences Corporation

$78.20

+0.10%

DXCM

DexCom, Inc.

$62.95

-0.27%

ALGN

Align Technology, Inc.

$184.69

+2.23%

PEN

Penumbra, Inc.

$332.17

+0.21%

SWAV

ShockWave Medical, Inc.

$334.75

-0.02%

MASI

Masimo Corporation

$178.39

-0.04%